Ertugliflozin and Topiramate Interaction

Drug interaction information between Ertugliflozin and Topiramate.

Ertugliflozin and Topiramate have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Ertugliflozin and Topiramate. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Ertugliflozin

SGLT2 Inhibitor

Drug B

Topiramate

Anticonvulsant

How They Interact

Topiramate affects how the body handles acid, which can increase the risk of a serious condition called lactic acidosis when combined with metformin.

FDA Label Information

7 DRUG INTERACTIONS Table 3: Clinically Significant Drug Interactions with SEGLUROMET Carbonic Anhydrase Inhibitors Clinical Impact: The risk of lactic acidosis may increase due to concomitant use of Topiramate or other carbonic anhydrase inhibitors (e.g., zonisamide, acetazolamide or dichlorphenamide) with metformin.

Ertugliflozin Also Interacts With

View all Ertugliflozin interactions →

Frequently Asked Questions

What SPL severity band is on file for Ertugliflozin + Topiramate?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Topiramate has 30 labeled pairs on file vs Ertugliflozin's 8. In the moderate band specifically: Ertugliflozin has 6 (also Metformin, Dolutegravir, Ranolazine, Cimetidine); Topiramate has 3 (also Zonisamide, Alogliptin).

What mechanism field is on file for Ertugliflozin and Topiramate?

Topiramate affects how the body handles acid, which can increase the risk of a serious condition called lactic acidosis when combined with metformin.

Topiramate's labeled portfolio outnumbers Ertugliflozin

SPL source-record counts only. This page's band is moderate · classes on file: Ertugliflozin (SGLT2 Inhibitor); Topiramate (Anticonvulsant).

Ertugliflozin

0 major · 6 moderate · 2 minor · 8 total

Topiramate

0 major · 3 moderate · 27 minor · 30 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.